Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft (Marina Temkin/TechCrunch)

Marina Temkin / TechCrunch: Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft  —  For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn't isolate its active ingredient until the 1800s

Jun 14, 2024 - 08:00
182115
Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft (Marina Temkin/TechCrunch)

Marina Temkin / TechCrunch:
Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft  —  For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn't isolate its active ingredient until the 1800s

This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.